Metformin
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
University of Massachusetts, Worcester
Overview
Metformin is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Metformin clinical trials
Explore related
Medical disclaimer. This page summarizes research about Metformin for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.